Giraff Wins AAL Forum's Prestigious "Most Promising" Award

The Swedish company Giraff Technologies and the EU AAL ExCITE-project received top honors at the annual AAL Forum, being named the "most promising" innovation of the year out of nearly 100 products and projects. The three criteria for the award were innovation, potential to improve the quality of life for older adults and market potential.

"We are excited about what this award means for Giraff Technologies and Robotdalen's initiative in Sweden to promote new businesses within Technology for Independent Life," says Erik Lundqvist, General Manager at Robotdalen. "Our mission is to identify and nurture companies like Giraff Technologies."

The Ambient Assisted Living (AAL) Forum is the EU industry organization that supports and promotes technology solutions for independent life. Its stated objectives are to extend the time that elderly people can live independently in their homes, specifically through preventing social isolation, maintaining social networks, and increasing the efficiency and productivity of care resources.

"We are pleased to select Giraff and the ExCITE project for this award," said Lena Gustafsson, President of the AAL Association. "They can bring to this industry exciting opportunities for innovation, improving the quality of life for older adults and market success, which is what the 'most promising' award is all about."

Social interaction and security with Giraff
The Giraff is a mobile telepresence solution that achieves AAL goals by extending the presence of caregivers in elderly persons' homes. It allows caregivers to virtually enter a home over the Internet and conduct a natural visit, moving freely around the home just as if they were physically present. Giraff diminishes social isolation and provides greater security at home for the elderly. "ExCITE" is the EU AAL funded project led by Örebro University in Sweden that studies the interaction of elderly with their caregivers through the Giraff device.

"We owe our thanks for this award to our users - elderly persons and their caregivers who continue to evaluate the Giraff solution and provide us with invaluable feedback," says Stephen Von Rump, CEO of Giraff Technologies AB. "And to the ExCITE researchers who help structure this feedback and enable us to evolve the Giraff from a product to a complete support service. We also owe a huge debt to Robotdalen for their continued support, helping us move from Silicon Valley in the U.S. and establish our company here in Sweden."

About AAL Forum
The Ambient Assisted Living (AAL) Forum is the EU industry organization that supports and promotes technology solutions for independent life. Its stated objectives are to extend the time that elderly people can live independently in their homes, specifically through preventing social isolation, maintaining social networks, and increasing the efficiency and productivity of care resources.

About Giraff
The Giraff Technologies mission is to enable confidence for independent life amongst elderly in the EU. It combines the Giraff telepresence device with user software, care organization administrative tools and a growing knowledge base to implement the Giraff solution in the real world of elderly care.

About Robotdalen
Robotdalen is a Swedish robotics initiative that enables commercial success of new ideas and research within robotics and automation. It focuses on solutions for industry, heavy autonomous vehicles and technology for independent life.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...